Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-0918-0, published online 2 June 2020.
In the version of this article initially published, the date published was given as 01 June 2020. The correct date is 02 June 2020. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brastianos, P.K., Lee, E.Q., Cohen, J.V. et al. Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med 26, 1309 (2020). https://doi.org/10.1038/s41591-020-0978-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-0978-1
This article is cited by
-
Systemic Therapy Approaches for Breast Cancer Brain and Leptomeningeal Metastases
Current Treatment Options in Oncology (2022)
